Implantica AG (publ) announces that Stefan Vogt is joining as Chief Commercial Officer, having extensive experience in building large sales organisations. Stefan Vogt, the new Chief Commercial Officer, is responsible for the development and execution of commercialisation at Implantica. Stefan has a successful record of building commercialisation infrastructure and sales organizations in digital health and implant companies. Among other positions, he was previously Chief Commercial Officer at LifeWatch AG (a stock listed company at SIX Swiss, Zürich) and Director International Business at Preventice Solutions Inc. (the latter acquired by Boston Scientific), both digital health companies providing remote cardiac monitoring of patients. Stephan Siegenthaler has been promoted to Chief Strategy Officer and will guide and oversee the process.